title: Differences in impulsivity on a delay-discounting task predict self-administration of a low unit dose of methylphenidate in rats.
abstract: There is controversy about the abuse liability of methylphenidate (MPH) in humans, and MPH has yet to be established fully as a reinforcer in rats. The present experiment examined whether intravenous MPH served as a reinforcer in rats, and how individual differences in impulsivity impacted MPH self-administration. Rats were exposed to a delay-discounting procedure, and then were implanted with an intravenous catheter to assess self-administration of 0.56 mg/kg/infusion MPH at different fixed ratio values. Self-administration rates of different MPH doses (0.03-1.0 mg/kg/infusion) were also examined. Both high and low impulsive rats acquired MPH self-administration at the same rate. All rats pressed more on the active lever than the inactive lever regardless of MPH dose, and pressed more for MPH than for saline. High impulsive rats self-administered more MPH than low impulsive rats at a low unit dose (0.1 mg/kg/infusion), though not at higher doses, indicating that individual differences in impulsive choice influence the dose-dependent reinforcing effects of MPH.
authors.affiliation: Center for Drug Abuse Research Translation (CDART), University of Kentucky, Lexington, Kentucky 40536, USA. jmarusich@uky.edu
authors.forename: Julie A
authors.initials: JA
authors.lastname: Marusich
authors.forename: Michael T
authors.initials: MT
authors.lastname: Bardo
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D002755:Choice Behavior / Q000187:drug effects*; D003216:Conditioning, Operant / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005108:Extinction, Psychological / Q000187:drug effects*; D007175:Impulsive Behavior / Q000503:physiopathology*; D008297:Male; D008774:Methylphenidate / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects; D012055:Reinforcement Schedule; D012646:Self Administration / Q000379:methods; D013997:Time Factors
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate
references.citation: Am J Psychiatry. 1998 Apr;155(4):493-8
references.pmid: 9545994
references.citation: Psychopharmacology (Berl). 2005 Mar;178(2-3):193-201
references.pmid: 15338104
references.citation: Psychopharmacology (Berl). 2001 Mar;154(3):243-50
references.pmid: 11351931
references.citation: J Exp Anal Behav. 2005 May;83(3):297-314
references.pmid: 16047609
references.citation: Pharmacol Biochem Behav. 2009 Feb;91(4):481-8
references.pmid: 19121334
references.citation: J Pharmacol Exp Ther. 1989 Oct;251(1):150-5
references.pmid: 2529365
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):34-41
references.pmid: 17714843
references.citation: J Am Acad Child Adolesc Psychiatry. 1997 Jan;36(1):37-44
references.pmid: 9000779
references.citation: Am Psychol. 2002 Dec;57(12):1060-73
references.pmid: 12613157
references.citation: Psychopharmacology (Berl). 1999 Oct;146(4):348-61
references.pmid: 10550486
references.citation: J Pharmacol Exp Ther. 1975 May;193(2):676-88
references.pmid: 1142112
references.citation: Psychol Bull. 1975 Jul;82(4):463-96
references.pmid: 1099599
references.citation: Biol Psychiatry. 2005 Jun 1;57(11):1231-8
references.pmid: 15949993
references.citation: Science. 2008 Jun 6;320(5881):1352-5
references.pmid: 18535246
references.citation: Pediatrics. 2006 Jun;117(6):2030-9
references.pmid: 16740845
references.citation: J Exp Psychol Gen. 1999 Mar;128(1):78-87
references.pmid: 10100392
references.citation: Psychopharmacology (Berl). 2005 Jul;180(2):294-305
references.pmid: 15717210
references.citation: Exp Clin Psychopharmacol. 1998 Aug;6(3):292-305
references.pmid: 9725113
references.citation: Biol Psychiatry. 2008 Feb 1;63(3):301-8
references.pmid: 17884016
references.citation: Psychopharmacology (Berl). 2003 Dec;170(4):390-8
references.pmid: 13680085
references.citation: J Abnorm Psychol. 2003 Aug;112(3):497-507
references.pmid: 12943028
references.citation: Am J Addict. 2007;16 Suppl 1:24-32; quiz 33-4
references.pmid: 17453604
references.citation: Psychopharmacology (Berl). 2002 Aug;162(4):373-8
references.pmid: 12172690
references.citation: J Neurosci. 2000 Jun 1;20(11):4226-32
references.pmid: 10818158
references.citation: J Psychopharmacol. 2010 Mar;24(3):309-21
references.pmid: 19074531
references.citation: Exp Clin Psychopharmacol. 2003 Feb;11(1):18-25
references.pmid: 12622340
references.citation: Behav Pharmacol. 2001 Jul;12(4):267-75
references.pmid: 11548112
references.citation: Mayo Clin Proc. 2000 Jul;75(7):711-21
references.pmid: 10907387
references.citation: J Psychopharmacol. 1999;13(2):180-92
references.pmid: 10475725
references.citation: Behav Pharmacol. 1995 Dec;6(8):810-814
references.pmid: 11224384
references.citation: Psychopharmacology (Berl). 1999 Oct;146(4):455-64
references.pmid: 10550496
references.citation: Pharmacol Biochem Behav. 1984 Feb;20(2):227-32
references.pmid: 6144109
references.citation: Psychopharmacology (Berl). 1999 Oct;146(4):447-54
references.pmid: 10550495
references.citation: Exp Clin Psychopharmacol. 2008 Apr;16(2):165-77
references.pmid: 18489020
references.citation: Behav Pharmacol. 2005 Feb;16(1):15-23
references.pmid: 15706134
references.citation: Psychopharmacology (Berl). 1993;110(1-2):5-12
references.pmid: 7870898
references.citation: Psychopharmacology (Berl). 2007 Aug;193(2):215-23
references.pmid: 17406857
references.citation: Pharmacol Biochem Behav. 2001 Mar;68(3):611-27
references.pmid: 11325419
references.citation: J Abnorm Psychol. 2003 Aug;112(3):382-92
references.pmid: 12943017
references.citation: Exp Clin Psychopharmacol. 1999 Aug;7(3):284-93
references.pmid: 10472517
references.citation: Exp Clin Psychopharmacol. 1997 Aug;5(3):256-62
references.pmid: 9260073
references.citation: Psychopharmacology (Berl). 2007 Jun;192(2):193-206
references.pmid: 17277934
references.citation: Arch Pediatr Adolesc Med. 2002 Mar;156(3):217-24
references.pmid: 11876664
references.citation: Psychopharmacology (Berl). 1999 Oct;146(4):373-90
references.pmid: 10550488
references.citation: Psychopharmacology (Berl). 1984;82(1-2):6-13
references.pmid: 6141585
references.citation: Psychopharmacologia. 1971;22(3):271-81
references.pmid: 4399836
references.citation: Neuropsychopharmacology. 2005 Apr;30(4):758-64
references.pmid: 15526000
references.citation: Biol Psychiatry. 1998 Aug 15;44(4):269-73
references.pmid: 9715358
references.citation: Psychopharmacology (Berl). 2003 Nov;170(3):320-331
references.pmid: 12955303
references.citation: Neuropsychopharmacology. 2008 Apr;33(5):1149-61
references.pmid: 17568395
references.citation: Neural Netw. 2002 Jun-Jul;15(4-6):617-34
references.pmid: 12371516
references.citation: Curr Protoc Neurosci. 2005 Aug;Chapter 9:Unit 9.20
references.pmid: 18428629
references.citation: Psychopharmacology (Berl). 2008 Jul;199(1):55-66
references.pmid: 18483809
references.citation: Clin Psychol Rev. 2006 Aug;26(4):379-95
references.pmid: 16504359
references.citation: J Pharmacol Exp Ther. 2003 Oct;307(1):356-66
references.pmid: 12954808
references.citation: Behav Brain Res. 2008 Nov 3;193(1):48-54
references.pmid: 18534693
references.citation: J Psychoactive Drugs. 2000 Jan-Mar;32(1):67-79
references.pmid: 10801069
references.citation: Behav Brain Res. 2002 Mar 10;130(1-2):73-8
references.pmid: 11864720